The Board of Regents of The University of Texas System
发明人:
DICKEY, BURTON,TUVIM, MICHAEL,EVANS, SCOTT
申请号：
PL10716433
公开号：
PL2411521T3
申请日:
2010.03.25
申请国别(地区):
PL
年份:
2015
代理人:
摘要：
Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a TLR9 agonist and a TLR 2/6 agonist to the individual.
